Baseline | Follow-up | |
N | 48 | 42 |
Age (years), Mean (SD) | 6 (3.37) | 7 (2.9) |
Gender (% males) | 81 | 80 |
Diagnosis n (%) | ||
Autistic Disorder | 25 (52) | 24 (57) |
Asperger Syndrome | 6 (13) | 4 (10) |
PDD-NOS | 17 (35) | 14 (33) |
VABS-Composite, mean (SD) | 60 (18.7)a | 62.9 (17.9)b |
WPPSI-III/WISC-III, mean (SD) | 82.4 (18.9)c | 83 (24.3)d |
Leiter-R, mean (SD) | 48.3 (16.2)e | 50.1 (17.9)f |
PEP3-CVP, mean (SD) | 43.6 (22.3)g | 48.9 (24.2)h |
PEP3-CP, mean (SD) | 7.6 (3.5)i | 6.7 (2.2)j |
PEP3-AP, mean (SD) | 10.6 (2.7)i | 12.5 (0.8)j |
PEP3-CA, mean (SD) | 10.4 (2.4)i | 10.6 (2.6)j |
ADOS-A, mean (SD) | 2.1 (3.3)k | 1.7 (0.4)l |
ADOS-B, mean (SD) | 2.5 (4.4)k | 1.8 (0.3)l |
DD-CGAS, mean (SD) | 57.5 (13.4) | 62.9 (11) |